Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.
Press releases published on September 25, 2025
Buying Guide -Instant female arousal pills over the counter 2025 By OhYes
Washington DC, Sept. 25, 2025 (GLOBE NEWSWIRE) -- OhYes brand today announced the release of its groundbreaking 2025 Buying Guide – Instant Female Arousal Pills Over the Counter, offering consumers clear, research-driven insights into one of the fastest- …
AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition
DOVER, Del., Sept. 25, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (Nasdaq: ATON), a specialized digital asset treasury company focused on the Telegram ecosystem, today announced the successful closing of its …
Andersen Sterilizers Launches EOGas 4PLUS: Next-Generation Low-Temperature Sterilization
Haw River, North Carolina , Sept. 25, 2025 (GLOBE NEWSWIRE) -- Andersen Sterilizers, a global leader in low-temperature ethylene oxide (EO) sterilization, announces the launch of EOGas 4PLUS, a state-of-the-art system designed to meet the evolving needs of …
AIMイムノテック (AIM ImmunoTech)、アンプリジェン (Ampligen®)(リンタトリモド) とチェックポイント阻害剤を併用する新規がん治療に関する特許を日本で2039年まで取得
この特許は、ライセンス供与、共同研究、長期的な収益成長の機会を提供し、国際市場での保護拡大を目指すAIMの戦略を支えるものである 日本は世界第3位の医薬品市場であり、がん領域は最も成長が速い治療分野である フロリダ州オカラ発, Sept. 26, 2025 (GLOBE NEWSWIRE) -- AIMイムノテック (AIM ImmunoTech Inc.) (NYSE American: AIM) (「AIM」または「同社」) は本日、日本特許庁が同社独自のアンプリジェン (Ampligen®) …
PetVivo Animal Health Expands Veterinary Education with New RACE-Approved CE Courses on Osteoarthritis and Regenerative Therapies
On-demand programs deliver clinically relevant science, technical instruction, and case applications in small animal and equine practice MINNEAPOLIS, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PetVivo Animal Health, a subsidiary of PetVivo Holdings, Inc. (OTCQX: …
Theratechnologies Announces Completion of Acquisition by Future Pak
MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of …
Theratechnologies annonce la réalisation de l’acquisition par Future Pak
MONTRÉAL, 25 sept. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade de la commercialisation, a annoncé aujourd’hui la réalisation du plan d’ …
WORK Medical Technology Group LTD Announces Pricing of $2.9 Million Registered Direct Offering
Hangzhou, China, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and …
Advanced Liver Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight
New York, USA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Advanced Liver Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight The advanced liver cancer market is positioned for strong growth as rising …
Global Wearable Medical Devices Market is Predicted to Reach USD 185 Billion by 2032 | DelveInsight
New York, USA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Global Wearable Medical Devices Market is Predicted to Reach USD 185 Billion by 2032 | DelveInsight The global wearable medical devices market is experiencing rapid growth, driven by the increasing burden …
Acıbadem Hospitals Launch “Ready for All Rounds” In‑Hospital Campaign for Breast Cancer Awareness Month
ISTANBUL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Breast Cancer Awareness Month, observed every October worldwide, is a global health campaign recognised by the World Health Organization and leading cancer societies. Symbolised by the pink ribbon, the month is …
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
OSE Immunotherapeutics Reports its Cash Position as of June 30, 2025 Nantes, France, September 25, 2025, 6 p.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) reports its cash position as of June 30, 2025. Due to the Company’s Annual …
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025 Nantes, France – le 25 septembre 2025 à 18h00 – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) publie sa position de trésorerie au 30 juin 2025. En raison du report de …
AbbVie’s Rinvoq Gains Early Traction in Giant Cell Arteritis Market, Expanding Options for Rheumatologists
EXTON, PA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Rheumatologists report high satisfaction with AbbVie’s Rinvoq (upadacitinib) following its recent approval in giant cell arteritis (GCA), with the majority citing anticipated efficacy, steroid-sparing benefits, …
Arkansas Psychological Association Announces Fall 2025 Conference on Suicide Prevention and Mental Health
Little Rock, Arkansas, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The Arkansas Psychological Association (ArPA) will host its Fall 2025 Conference, "Turning the Tide: Strengthening Hope, Connection, and Community," on October 9–10, 2025, in Little Rock, AR. This …
The YMCA Helps Older Adults Thrive in Body, Mind, and Spirit
CHICAGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Approximately 24% of Americans aged 65 and older are socially isolated. As the holiday season approaches, a time when loneliness can weigh heavily on older adults, the YMCA is stepping up efforts to foster health …
Fireflies launches HIPAA-compliant AI assistant to ease clinician burnout and transform healthcare documentation
SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Fireflies.ai, the #1 AI teammate for meetings used by people at 75% of Fortune 500 companies, today announced Fireflies for Healthcare, a HIPAA-compliant documentation solution that gives healthcare …
World’s First Fully Robotic Procedure by a Gastroenterologist Completed Using EndoQuest’s Endoluminal Surgical System in the PARADIGM Trial
Houston, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced the completion of the first procedure performed by a gastroenterologist in the PARADIGM Trial ( …
ACMA & APLCM Announce 2025 Leadership and Physician Advisor Conference in Boston, MA—Featuring Keynote by Renowned Speaker Antonio Neves and Exclusive Opportunities for Physicians
Boston, MA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The American Case Management Association (ACMA) and the Association of Physician Leadership in Care Management (APLCM) are proud to host the 2025 Leadership and Physician Advisor Conference (LPAC), taking …